Conference · Washington, District of Columbia
CHI’S Translational Cancer Medicine
Health · Medicine · Pharmaceuticals
Key numbers
- Editions on record
- 5first in 2009
About CHI’S Translational Cancer Medicine
Research of the molecular mechanisms of cancer, which is a complex disease, has benefitted from advances in “omic” and cellular technologies, offering new opportunities for diagnostic and therapeutic development. The Translational Cancer Medicine track of ADAPT 2012 Congress focuses on the innovation in non-invasive diagnostics for cancer (including CTCs, circulating proteins and microRNA, and exosomes), advances in clinical genomics, and advances in targeted therapies.
Topics include:
Circulating tumor cells as markers for disease prognosis and treatment selection
New targets and biomarkers derived from the cancer genome research
Cancer stem cells as targets and biomarkers in new therapy development
Case studies in cancer-targeted therapies
Novel non-invasive diagnostics for cancer
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2012 | 19–21 Sep 2012 | Renaissance Washington D C Hotel Downtown Washington, District of Columbia | — | — |
| 2011 | 24–25 Sep 2011 | Chicago Market Chicago, Illinois | — | — |
| 2010 | 13–16 Sep 2010 | Hyatt Regency Crystal City Arlington, Virginia | — | — |
| 2010 | 15 Jan 2010 | — | — | |
| 2009 | 26–28 Jan 2009 | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is CHI’S Translational Cancer Medicine?
The next dates haven't been confirmed. The last edition we have on record was 19–21 Sep 2012.
Where is it held?
The last edition we have was at Renaissance Washington D C Hotel Downtown, Washington, District of Columbia.
How often does it take place?
Annual, judging by the 5 editions on record since 2009.